Literature DB >> 24002906

The increasing burden of hypertension in Nigeria - can a dietary salt reduction strategy change the trend?

Kenechukwu Mezue1.   

Abstract

Developing countries face a dual challenge of both communicable and non-communicable disease - 80% of deaths from cardiovascular disease occur in low and middle-income countries. Hypertension ranks highest as an attributable cause of mortality in both developed and developing countries. The prevalence of hypertension is rising rapidly in Nigeria, from 11% two decades ago to about 30% in recent times. This review explores salt reduction in the diet at the population-wide level as a means of reducing the burden of hypertension in Nigeria. The evidence behind this strategy is explored, methods of how this goal was achieved in other countries are investigated and recommendations on how it could be accomplished in the Nigerian context are considered. There are suggestions that if salt reductions are effectively implemented on a population-wide basis, it will have an impact on morbidity and mortality as large as that which the provision of drains and safe water had in the 19(th) century. © Royal Society for Public Health 2013.

Entities:  

Keywords:  Nigeria; hypertension; non-communicable diseases; salt reduction

Mesh:

Substances:

Year:  2013        PMID: 24002906     DOI: 10.1177/1757913913499658

Source DB:  PubMed          Journal:  Perspect Public Health        ISSN: 1757-9147


  9 in total

1.  Stage 2 Hypertension and Electrocardiogram Abnormality: Evaluating the Risk Factors of Cardiovascular Diseases in Nigeria.

Authors:  Shalom Nwodo Chinedu; Franklyn Nonso Iheagwam; Michael Kemjika Onuoha; Grace Nkechi Joshua; Opeyemi Christianah DeCampos
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-02-04

Review 2.  Current Prevalence Pattern of Hypertension in Nigeria: A Systematic Review.

Authors:  James Tosin Akinlua; Richard Meakin; Aminu Mahmoud Umar; Nick Freemantle
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

Review 3.  Salt Reduction Interventions in Sub-Saharan Africa: A Systematic Review.

Authors:  Stella Kagwiria Muthuri; Samuel Oji Oti; Richard James Lilford; Oyinlola Oyebode
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

4.  Prevalence of HTN in Iran: Meta-analysis of Published Studies in 2004-2018.

Authors:  Mehdi Jafari Oori; Farahnaz Mohammadi; Kian Norozi; Masoud Fallahi-Khoshknab; Abbas Ebadi; Reza Ghanei Gheshlagh
Journal:  Curr Hypertens Rev       Date:  2019

Review 5.  Sodium Reduction in Bouillon: Targeting a Food Staple to Reduce Hypertension in Sub-saharan Africa.

Authors:  Nicholas S Archer; Maeva Cochet-Broch; Mihaela Mihnea; Gonzalo Garrido-Bañuelos; Patricia Lopez-Sanchez; Leif Lundin; Damian Frank
Journal:  Front Nutr       Date:  2022-02-02

6.  Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis.

Authors:  Davies Adeloye; Catriona Basquill
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

7.  Treatment adherence and blood pressure outcome among hypertensive out-patients in two tertiary hospitals in Sokoto, Northwestern Nigeria.

Authors:  Rasaq Adisa; Olumide Ayodeji Ilesanmi; Titilayo Oyelola Fakeye
Journal:  BMC Cardiovasc Disord       Date:  2018-10-19       Impact factor: 2.298

Review 8.  Monitoring and implementation of salt reduction initiatives in Africa: A systematic review.

Authors:  Dejen Yemane Tekle; Joseph Alvin Santos; Kathy Trieu; Sudhir Raj Thout; Rhoda Ndanuko; Karen Charlton; Annet C Hoek; Mark D Huffman; Stephen Jan; Jacqui Webster
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-08       Impact factor: 3.738

Review 9.  Barriers, Enablers, and Perceptions on Dietary Salt Reduction in the Out-of-Home Sectors: A Scoping Review.

Authors:  Viola Michael; Yee Xing You; Suzana Shahar; Zahara Abdul Manaf; Hasnah Haron; Siti Nurbaya Shahrir; Hazreen Abdul Majid; Yook Chin Chia; Mhairi Karen Brown; Feng J He; Graham A MacGregor
Journal:  Int J Environ Res Public Health       Date:  2021-07-30       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.